In terms of the development of vaccines in Canada, the main project we had in Canada was this partnership with the Chinese company. It didn't work. If you look at the global level—the contribution of different governments, basically—more than half of the contributions, in terms of investment, are first and foremost public investments. In Canada, the new challenger in terms of a vaccine is now with Medicago. It's still in clinical trials, but let's just say that it would be an interesting surprise if it could go through because we would have here a very significant production capacity for this.
